(PRRT) of Gastro-Entero-Pancreatic NeuroEndocrine Tumors
(PRRT) of Gastro-Entero-Pancreatic NeuroEndocrine Tumors
(PRRT) of Gastro-Entero-Pancreatic NeuroEndocrine Tumors
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
[177Lu-DOTA0,Tyr3]Octreotate Therapy<br />
N = 50 GEP-NET<br />
EORTC-QLQ-C30 Questionnaire<br />
Percentage <strong>of</strong> Patients with Improvement<br />
100<br />
90<br />
80<br />
70<br />
60<br />
50<br />
40<br />
30<br />
20<br />
10<br />
0<br />
9/12<br />
30/43<br />
29/43<br />
21/29<br />
15/25<br />
16/22<br />
9/25<br />
Global QoL Fatigue Nausea Pain Dyspnea Insomnia Diarrhea<br />
Symptom Scales<br />
Overall improvement in 70 % <strong>of</strong> patients, excl for dyspnea<br />
50 % <strong>of</strong> patients were already on SS analogs !!
Change language